Trials / Active Not Recruiting
Active Not RecruitingNCT05504070
Venclose digiRF System Post Market Study
Venclose digiRF System: A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 203 (estimated)
- Sponsor
- C. R. Bard · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Venclose System (digiRF generator w EVSRF catheter) | The Venclose System is intended for use in endovascular coagulation of blood vessels in patients with superficial vein reflux. |
| DEVICE | Venclose MAVEN System (digiRF generator w MAVEN catheter) | The Venclose MAVEN System is intended for use in endovascular coagulation of blood vessels in patients with perforator or tributary vein reflux. |
Timeline
- Start date
- 2023-09-08
- Primary completion
- 2025-07-17
- Completion
- 2027-06-01
- First posted
- 2022-08-17
- Last updated
- 2026-03-18
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05504070. Inclusion in this directory is not an endorsement.